GTR Home > Tests > Dihydropyrimidin Dehydrogenase deficiency

Overview

Test name

Help

Dihydropyrimidin Dehydrogenase deficiency

Purpose of the test

Help

This is a clinical test intended for Help: Diagnosis

Condition

Help

1 condition tested. Click Indication tab for more information.

Methodology

Help
Molecular Genetics
DDeletion/duplication analysis
Multiplex Ligation-dependent Probe Amplification (MLPA)
TTargeted variant analysis
Other

Summary of what is tested

1 genes and variants. Click Methodology tab for more information.

Genes

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

How to order

Help

Not provided

Practice guidelines

  • CPIC, 2013
    Clinical pharmacogenetics implementation consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
  • DailyMed Drug Label, 2012
    DailyMed Drug Label, ADRUCIL, 2012

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.